Post‐acute sequelae of <scp>COVID</scp>‐19 in cancer patients: Two cohorts in <scp>UK</scp> and Hong Kong
COVID-19 infection is associated with increased risks of CVDs and mortality in cancer patients. Fully vaccination may reduce the post-acute effects of COVID-19 on CVDs. This information may guide effective pre-emptive measures to reduce COVID-19-related morbidities and mortality in cancer patients.
Authors
- Celine Sze Ling Chui (ORCID: https://orcid.org/0000-0003-1513-8726)
- Eric Yuk Fai Wan (ORCID: https://orcid.org/0000-0002-6275-1147)
- Esther W. Chan (ORCID: https://orcid.org/0000-0002-7602-9470)
- Francisco Tsz Tsun Lai (ORCID: https://orcid.org/0000-0002-9121-1959)
- Shing Fung Lee (ORCID: https://orcid.org/0000-0003-4696-9434)
- Vincent Ka Chun Yan (ORCID: https://orcid.org/0000-0001-5225-3032)
- Ian Chi Kei Wong (ORCID: https://orcid.org/0000-0001-8242-0014)
- Xue Li (ORCID: https://orcid.org/0000-0003-4836-7808)
- Jiayi Zhou (ORCID: https://orcid.org/0000-0001-7204-2662)
- Carlos King Ho Wong
Institutions
- Hospital Authority (HK)
- Aston University (GB)
- Chinese University of Hong Kong (HK)
- Tuen Mun Hospital (CN)
- Hong Kong Science and Technology Parks Corporation (HK)
- National University Cancer Institute, Singapore (SG)
- City University of Hong Kong, Shenzhen Research Institute (CN)
- University of Hong Kong - Shenzhen Hospital (CN)
- National University Hospital (SG)
- Laboratory of Data Discovery for Health (HK)
- University of Hong Kong (HK)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/cam4.70134
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amgen
- Bristol-Myers Squibb
- Pfizer
- World Health Organization
- Wellcome Trust
- National Institute for Health and Care Research
- European Commission
- University Grants Committee
- University of Hong Kong
- Medical Research Council
- National Health and Medical Research Council
- Health and Medical Research Fund